{"disease":{"id":"moderate-to-severe-alzheimer-s-disease","name":"moderate to severe alzheimer s disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04229927","title":"BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":712,"lead_sponsor_name":"Hyundai Pharmaceutical Co., LTD.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}